Bristol-Myers to Take a $3B Tax Hit in Q4 2017 Post author:Sam Post published:January 7, 2018 Post category:BioPharma The expense is primarily related to taxes on unremitted offshore earnings, the company said. Source: BioSpace You Might Also Like <b>Blue Ribbon</b> Highlights Session Recognizes Best Posters From 21st <b>International Congress Of Parkinson???s Disease And Movement Disorders</b> June 8, 2017 Novartis' Sandoz Jobs on the Chopping Block February 8, 2018 AbbVie's $175 Million Gamble Pays Off as Ablynx RA Drug Meets Goal in Phase II Study July 8, 2016
<b>Blue Ribbon</b> Highlights Session Recognizes Best Posters From 21st <b>International Congress Of Parkinson???s Disease And Movement Disorders</b> June 8, 2017